These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7530318)

  • 21. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in Chlamydia trachomatis strains selected in vitro by macrolide passage.
    Zhu H; Wang HP; Jiang Y; Hou SP; Liu YJ; Liu QZ
    Andrologia; 2010 Aug; 42(4):274-80. PubMed ID: 20629652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consequences of methotrexate inhibition of purine biosynthesis in L5178Y cells.
    Hryniuk WM; Brox LW; Henderson JF; Tamaoki T
    Cancer Res; 1975 Jun; 35(6):1427-32. PubMed ID: 1055632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-trimoxazole synergy in sensitive and resistant bacteria [proceedings].
    Amyes SG; Dible D
    J Pharm Pharmacol; 1979 Dec; 31 Suppl():32P. PubMed ID: 42706
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of dfrA14 in two distinct plasmids conferring trimethoprim resistance in Actinobacillus pleuropneumoniae.
    Bossé JT; Li Y; Walker S; Atherton T; Fernandez Crespo R; Williamson SM; Rogers J; Chaudhuri RR; Weinert LA; Oshota O; Holden MT; Maskell DJ; Tucker AW; Wren BW; Rycroft AN; Langford PR;
    J Antimicrob Chemother; 2015 Aug; 70(8):2217-22. PubMed ID: 25957382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Damage/Danger Associated Molecular Patterns (DAMPs) Modulate Chlamydia pecorum and C. trachomatis Serovar E Inclusion Development In Vitro.
    Leonard CA; Schoborg RV; Borel N
    PLoS One; 2015; 10(8):e0134943. PubMed ID: 26248286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Fluorouracil-resistant strain of Methanobacterium thermoautotrophicum.
    Nagle DP; Teal R; Eisenbraun A
    J Bacteriol; 1987 Sep; 169(9):4119-23. PubMed ID: 3624203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of resistance to rifampin and rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis.
    Kutlin A; Kohlhoff S; Roblin P; Hammerschlag MR; Riska P
    Antimicrob Agents Chemother; 2005 Mar; 49(3):903-7. PubMed ID: 15728882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-acylated derivatives of sulfamethoxazole and sulfafurazole inhibit intracellular growth of Chlamydia trachomatis.
    Marwaha S; Uvell H; Salin O; Lindgren AE; Silver J; Elofsson M; Gylfe A
    Antimicrob Agents Chemother; 2014 May; 58(5):2968-71. PubMed ID: 24566180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of trimethoprim and its antagonists on RNA synthesis in Escherichia coli.
    Then R; Angehrn P
    Biochim Biophys Acta; 1972 Nov; 287(1):98-105. PubMed ID: 4569161
    [No Abstract]   [Full Text] [Related]  

  • 30. Lack of mutation in macrolide resistance genes in Chlamydia trachomatis clinical isolates with decreased susceptibility to azithromycin.
    Bhengraj AR; Srivastava P; Mittal A
    Int J Antimicrob Agents; 2011 Aug; 38(2):178-9. PubMed ID: 21570258
    [No Abstract]   [Full Text] [Related]  

  • 31. Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics.
    Jones RB; Van der Pol B; Martin DH; Shepard MK
    J Infect Dis; 1990 Dec; 162(6):1309-15. PubMed ID: 2230260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure.
    Somani J; Bhullar VB; Workowski KA; Farshy CE; Black CM
    J Infect Dis; 2000 Apr; 181(4):1421-7. PubMed ID: 10762573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the deoxyribonucleoside triphosphate pools of mouse 5178Y lymphoma cells following exposure to methotrexate or 5-fluorouracil.
    Tattersall MH; Harrap KR
    Cancer Res; 1973 Dec; 33(12):3086-90. PubMed ID: 4543390
    [No Abstract]   [Full Text] [Related]  

  • 34. Tetracycline-resistant Chlamydia trachomatis in Toulouse, France.
    Lefevre JC; Lepargneur JP; Guion D; Bei S
    Pathol Biol (Paris); 1997 May; 45(5):376-8. PubMed ID: 9296087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells.
    Zhen YS; Taniki T; Weber G
    Oncol Res; 1992; 4(2):73-8. PubMed ID: 1596584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the in vitro development of drug resistance of Proteeae to sulfonamides, trimethoprim and combinations of a sulfonamide and trimethoprim.
    Grunberg E; Beskid G
    Chemotherapy; 1977; 23(5):309-13. PubMed ID: 332463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trimethoprim-resistant bacteria: cross-resistance patterns.
    Grey D; Hamilton-Miller JM
    Microbios; 1977; 19(75):45-54. PubMed ID: 567736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of replication of multidrug-resistant HIV type 1 variants by combinations of thymidylate synthase inhibitors with zidovudine or stavudine.
    Gao WY; Johns DG; Tanaka M; Mitsuya H
    Mol Pharmacol; 1999 Mar; 55(3):535-40. PubMed ID: 10051538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of trimethoprim and sulfisoxazole, alone and in combination, on growth and carriage of Neisseria meningitidis.
    Feldman HA
    J Infect Dis; 1973 Nov; 128():Suppl:723-30 p. PubMed ID: 4202210
    [No Abstract]   [Full Text] [Related]  

  • 40. Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidine.
    Findenig G; Mader RM; Fritzer-Szekeres M; Steger GG; Jaeger W; Szekeres T
    Oncol Res; 1996; 8(5):189-96. PubMed ID: 8884811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.